Skip to content

Clinical trials

Completed Phase 1/2 Alzheimer Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Phase 1/2 Status: Completed Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20044
20061
20071
20081
20091
20102
20132
20142
20152
20161
20176
20183
20194
20204
20216
20223
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Annovis Bio Inc.2
Brigham and Women's Hospital2
Cognition Therapeutics2
Jeff Burns, MD2
Massachusetts General Hospital2
Medipost Co Ltd.2
Oregon Health and Science University2
The University of Texas Health Science Center at San Antonio2
AC Immune SA1
Alzamend Neuro, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease46
Dementia11
Cognitive Dysfunction7
Inflammation3
Central Nervous System Diseases2
Parkinson Disease2
Amyloid Neuropathies, Familial1
Amyloidosis1
Amyloidosis, Familial1
Amyotrophic Lateral Sclerosis1

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.